Background Targeted lung cancer screening is effective in reducing mortality by upwards of
twenty percent. However, screening is not universally available and uptake is variable and …

Lung cancer is the number one cause of cancer death worldwide. The benefits of lung
cancer screening to reduce mortality and detect early‐stage disease are no longer in any …

Background The purpose of this study is to undertake a comprehensive systematic review to
describe multilevel factors (barriers and facilitators) that may influence the implementation of …

Importance Screening for lung cancer using low-dose computed tomography is associated
with reduced lung cancer–specific mortality, but uptake is low in the US; understanding how …

Background Lung cancer screening (LCS) using low-dose CT imaging is recommended for
people at high risk of dying of lung cancer. Communication strategies for clinicians have …

Numerous factors contribute to the low adherence to lung cancer screening (LCS) programs.
A theory-informed approach to identifying the obstacles and facilitators to LCS uptake is …

Background Lung cancer screening, despite its proven mortality benefit, remains vastly
underutilized. Previous studies examined knowledge, attitudes, and beliefs to better …

Introduction Participation in lung cancer screening (LCS) trials and real-world programs is
low, with many people at high-risk for lung cancer opting out of baseline screening after …

Lung cancer (LC) is the leading cause of cancer death in the USA for both men and women,
and also worldwide, it is the commonest cause of cancer death. The five-year survival rate …

Background Annual lung cancer screening (LCS) has mortality benefits for eligible
participants; however, studies demonstrate low adherence to follow-up LCS. Research …